Probiotics, explained honestly.

What probiotics actually are

Probiotics are live microorganisms that, when taken in adequate amounts, confer a health benefit on the host (FAO/WHO 2002 definition, updated by Hill 2014). The word is Greek for "for life" — distinguishing them from antibiotics ("against life").

The most common probiotic organisms are bacteria from the Lactobacillus, Bifidobacterium, and Bacillus genera, plus the yeast Saccharomyces boulardii. Your gut already contains ~38 trillion bacteria (Sender 2016) — probiotics are not replacing your microbiome, they're adding specific strains with documented effects to it.

How probiotics work (and why most claims fail)

Probiotics work through several well-mapped mechanisms. The problem: most multi-strain products don't reach the gut alive, don't colonize, and don't produce measurable effects beyond placebo for most conditions.

1. Competitive exclusion. Probiotic bacteria compete with pathogens for binding sites and nutrients on the gut lining. Well-documented for Saccharomyces boulardii and certain Lactobacillus rhamnosus strains.
2. Short-chain fatty acid (SCFA) production. Some strains produce butyrate, propionate, and acetate — the preferred fuel for colonocytes. Linked to gut barrier integrity and immune regulation.
3. Bile acid metabolism. Some strains deconjugate bile acids, affecting cholesterol metabolism and gut motility.
4. Immune modulation. Specific strains (L. rhamnosus GG, B. lactis HN019) modulate dendritic cell and T-cell activity. Strain-specific effects — not generalizable.
5. Vitamin synthesis. Some strains synthesize vitamin K2, B12, folate, riboflavin. But the contribution to host nutrition is small.

The reality: most probiotic products do not measurably alter the gut microbiome in healthy adults. They pass through, transiently interact, and are excreted. For most conditions, the evidence is either weak, mixed, or specific to strains you can't buy off the shelf.

4 probiotic myths worth forgetting

The 4 categories of probiotic products

Strain-specificity matters more than anything else

The single most important fact about probiotics: effects are strain-specific. Lactobacillus rhamnosus GG is not interchangeable with Lactobacillus rhamnosus LGG-claim-but-actually-different-strain. The genus/species labels on the front of the bottle tell you almost nothing — the strain designation (GG, HN019, 35624, etc.) on the back is what matters.

This is why "broad-spectrum multi-strain" products are usually worse than targeted single-strain products:

• Multi-strain blends often include strains that antagonize each other in vitro.
• The marketing "more strains = better" is unproven — sometimes the opposite.
• Most strain-specific evidence comes from single-strain RCTs.
• Generic multi-strain products rarely list the strain designation on the label.

CFU and dose — what to look for

CFU at time of manufacture vs CFU at expiry is the trick. Reputable brands list CFU at expiry, not at manufacture (which is meaningless if the product sits on a shelf for 12 months). Here's the realistic dose by category:

• S. boulardii: 5-10 billion CFU/day for antibiotic-associated diarrhea prevention. Most products deliver 5 billion CFU.
• Lactobacillus rhamnosus GG: 10-20 billion CFU/day for general use.
• Bifidobacterium 35624 (Align): 1 billion CFU/day — counter-intuitively low dose, but it's the dose that worked in the trials.
• Visbiome (multi-strain for UC): 450-900 billion CFU/day — much higher dose, only used under medical supervision.
• Bacillus coagulans: 1-2 billion CFU/day is typical.

General rule: 5-50 billion CFU/day of a documented strain at expiry is the dose range most evidence supports. More is not better.

Where probiotics actually help (evidence-based)

Frequently asked questions

References & sources

1. Hill C, et al. (2014). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology 11(8):506-514. doi.org/10.1038/nrgastro.2014.66
2. McFarland LV. (2010). Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World Journal of Gastroenterology 16(18):2202-2222. doi.org/10.3748/wjg.v16.i18.2202
3. Goldenberg JZ, et al. (2017). Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database of Systematic Reviews. PMID: 29308853
4. Suez J, et al. (2018). Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT. Cell 174(6):1406-1423. doi.org/10.1016/j.cell.2018.08.047
5. Whorwell PJ, et al. (2006). Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome. American Journal of Gastroenterology 101(7):1581-1590. PMID: 16863564
6. NIH Office of Dietary Supplements — Probiotics Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Probiotics-HealthProfessional/
7. Examine.com — Probiotics research review. examine.com
8. Chemist Warehouse AU, iHerb, Amazon, Swisse AU, Blackmores AU, BioCeuticals AU, Herbs of Gold, Thorne, Mega We Care, Ethical Nutrients, Interpharma — product pages and price snapshots cited per row in the probiotic comparison table.